Device closure of a patent foramen ovale in a patient with lipomatous hypertrophy of the atrial septum.
The presence of a patent foramen ovale has been recognized as a risk factor for embolic stroke, and transcatheter device closure of patent foramen ovales is increasingly performed to reduce future neurological events. The present report discusses a patient who continued to have residual shunting following percutanous closure because of improper seating of the device in the presence of a lipomatous atrial septum.
Al-Faleh
H
H
University of Ottawa Heart Institute, Canada.
Marquis
J-F
JF
Chan
K L
KL
D006328:Cardiac Catheterization; D006332:Cardiomegaly / Q000150:complications* / Q000000981:diagnostic imaging / Q000601:surgery; D004452:Echocardiography; D005500:Follow-Up Studies; D006325:Heart Atria / Q000000981:diagnostic imaging; D006344:Heart Septal Defects, Atrial / Q000150:complications / Q000000981:diagnostic imaging / Q000601:surgery*; D006346:Heart Septum / Q000000981:diagnostic imaging; D006801:Humans; D008068:Lipomatosis / Q000150:complications* / Q000000981:diagnostic imaging / Q000601:surgery; D008297:Male; D008875:Middle Aged; D019736:Prostheses and Implants; D011474:Prosthesis Design; D019919:Prosthesis Implantation / Q000295:instrumentation*